Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs Go Vida Plena

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Go Vida Plena a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

Go Vida Plena

#277 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full Go Vida Plena review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 68 an est. $130/mo first month, with no teaser step-up baked in. Go Vida Plena isn't out of it: Shoppers who want spanish-speaking patients wanting a bilingual, Latino-food-friendly GLP-1 program from $199/mo.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareGo Vida Plena
Value Score91 (A)68 (C)
Est. first month$130/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~90%~85%
Semaglutide$130/moFrom $199/mo (starting dose, compounded)
Tirzepatide$163/moFrom $269/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
72
Gimme Care: 93. Go Vida Plena: 72.
88
No Teaser-Rate Bait
64
Gimme Care: 88. Go Vida Plena: 64.
98
Nationwide Availability
45
Gimme Care: 98. Go Vida Plena: 45.
92
Both Molecules
98
Gimme Care: 92. Go Vida Plena: 98.
84
Easy Cancellation
58
Gimme Care: 84. Go Vida Plena: 58.
82
Reputation
63
Gimme Care: 82. Go Vida Plena: 63.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

Go Vida Plena

Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.

Why it's a deal

  • Spanish-first, fully bilingual GLP-1 program tailored to Latino food and lifestyle - a genuinely underserved niche
  • Compounded semaglutide, tirzepatide, and oral semaglutide from $199/mo, with installment pay (Klarna, Afterpay, Affirm)
  • Free initial consultation; medications shipped discreetly to your door after a medical evaluation
  • Includes 24/7 support, 4 virtual visits a year, and ongoing nutrition coaching
  • Physician-supervised program (Utah medical backing) with continuous follow-up

The fine print

  • Utah-based, and the full list of states served is not published
  • Only a '$199/mo starting' price is shown upfront; tirzepatide and oral-semaglutide pricing isn't published
  • The compounding pharmacy is not named (a 'provider pharmacies' page exists but lists no name)
  • Compounded GLP-1 medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • No LegitScript certification displayed
Get the Gimme Care deal Get the Go Vida Plena deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to Go Vida Plena.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.